is the U.S. 'remotely prepared' for coronavirus (COVID-19)?

Posted by Neoteryx on Mar 30, 2020 2:00:00 PM

Fear over the recent coronavirus outbreak continues to manifest in extreme ways. Retail stores have run out of hand sanitizers; the stock market has plunged, and healthcare institutions are overwhelmed.

Read More

Topics: Clinical Trials, Remote Blood Collection, Remote Patient Monitoring, Viral Pathogens

what the coronavirus means for contract research organizations?

Posted by Neoteryx on Mar 23, 2020 7:00:00 AM

China has become the most popular region for clinical trial research over the last few years. A recent case study showed clinical trials had increased by 451% between years 2010 and 2017. This increasing investment by large companies like BeiGene, Ltd. is a result of the continuing effort by Chinese regulators to improve healthcare facilities to compete on a global scope.

Read More

Topics: Clinical Trials, Remote Patient Monitoring, Viral Pathogens

viral infection and immunity: the promise of remote sampling

Posted by Neoteryx on Mar 18, 2020 4:50:00 PM

We are living in unprecedented times.  On the 11th of March 2020, the world health organization upgraded the COVID-19 epidemic as a pandemic and different countries have implemented different ways to tackle the spread of this disease.   Much of this involves social distancing especially for the vulnerable in our societies.  

Read More

Topics: Clinical Trials, Remote Patient Monitoring, Viral Pathogens